The predominant treatment therapies in people with type 2 diabetes and hospitalization for hypoglycaemia were insulin monotherapy, insulin combined with one glucose‐lowering drug and SU monotherapy (Figure 3: B). This evidence concerns the gene INS and Hypoglycemia.